HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The natural history of Teflon catheter-associated phlebitis in children.

Abstract
During a prospective evaluation of intravenous therapy with peripheral Teflon catheters in children, we found 30 episodes of phlebitis (10.4%). This rate is less than that reported in adults. Catheter colonization was not related to phlebitic episodes, and catheter-related infections did not occur. No patient's hospital course was prolonged because of phlebitis. Thirty percent of the episodes developed after the catheter was removed, and premonitory symptoms were not helpful in predicting the onset of phlebitis. Factors associated with an increased phlebitic risk were parenteral nutrition, administration of nafcillin sodium or aminoglycosides, and patient age. Parenteral nutrition prolonged the course of phlebitis. No factors hastened the onset of phlebitis. The duration of cannulation was not significantly related to phlebitis, suggesting that in some children the catheters can remain in place longer than 72 hours.
AuthorsD B Nelson, J S Garland
JournalAmerican journal of diseases of children (1960) (Am J Dis Child) Vol. 141 Issue 10 Pg. 1090-2 (Oct 1987) ISSN: 0002-922X [Print] United States
PMID3115086 (Publication Type: Journal Article)
Chemical References
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Polytetrafluoroethylene
Topics
  • Adolescent
  • Age Factors
  • Aminoglycosides (adverse effects)
  • Anti-Bacterial Agents (adverse effects)
  • Catheterization (adverse effects)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Parenteral Nutrition, Total (adverse effects)
  • Phlebitis (etiology)
  • Polytetrafluoroethylene

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: